Evidence for this approach includes that ABCA1 loss-of-function mutations increase AD risk [56] and the reduced ability of lipoproteins isolated from the cerebrospinal fluid (CSF) of AD patients to accept cholesterol from ABCA1 compared to lipoproteins from age-matched controls [57]. Here, ABCA1 is linked to Alzheimer disease.